Tucatinib alleviates postmenopausal osteoporosis by suppressing osteoclast differentiation via regulating the DRP1/NFATc1/CTSK signaling pathway

Authors: Xin Liu, Shuang Liu, Guoqiang Xu et al.
Publication: Biochemical Pharmacology
Published: Aug 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Sparsity Learning via Structured Functional Factor Augmentation

Hanteng Ma, Ziliang Shen et al. - Jan 2029

Read More
Detecting Structural Breaks in High-dimensional Functional Time Series Factor Models

Caixia Xu, Huacheng Su et al. - Jan 2028

Read More
Mirror-Symmetric Orthogonal Latin Hypercubes with Attractive Space-Filling Properties

Chunyan Wang, Min-Qian Liu - Jan 2028

Read More
Subgroup Testing in Change-Plane Models and Its Applications to Medical Data

Xu Liu, Jian Huang et al. - Jan 2028

Read More
A Variation-Ratio Test for Volatility Jumps Using Noisy High Frequency Data

Guangying Liu, Kewen Shi et al. - Jan 2028

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Center Research Guides Citescore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0